Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus

The patient was a 73-year-old woman with lung adenocarcinoma and systemic lupus erythematosus (SLE) who was treated with pembrolizumab. After six cycles of pembrolizumab, she developed symptoms suggestive of neuropsychiatric SLE, such as resting tremor, confusional state, depression, mood disorder,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Jono, Misato, Kinehara, Yuhei, Utsu, Yoshihiko, Tamura, Yoshiro, Koseto, Masahiro, Murakami, Teruaki, Uota, Akifumi, Ninomiya, Ryusuke, Komo, Satoshi, Sumitani, Satoru, Sato, Bunzo, Kasayama, Soji, Tachibana, Isao
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056375/
https://ncbi.nlm.nih.gov/pubmed/31666468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3782-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados